Gadek-Michalska A, Bugajski J, Bugajski A J, Głód R
Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, Cracow.
J Physiol Pharmacol. 2002 Jun;53(2):275-87.
Nicotine is a potent stimulus for the hypothalamic-pituitary-adrenal (HPA) axis. Systemic nicotine acts via central mechanisms to stimulate by multiple pathways the release of ACTH from the anterior pituitary corticotrops and corticosterone from the adrenal cortex. Nicotine may stimulate indirectly the hypothalamic paraventricular nucleus, the site of the corticotropin-releasing hormone (CRH) neurons which activates ACTH release. In the present studies an involvement of adrenergic system and prostaglandins synthesized by constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2) in the nicotine-induced HPA response in rats was investigated. Nicotine (2.5-5 mg/kg i.p.) significantly increased plasma ACTH and corticosterone levels measured 1 hr after administration. Adrenergic receptor antagonists or COX inhibitors were injected i.p. 15 min prior to nicotine and the rats were decapitated 1 hr after the last injection. Prazosin (0.01-0.1 mg/kg), an alpha1-adrenergic antagonist, significantly decreased the nicotine-evoked ACTH and corticosterone secretion. Yohimbine (0.1-1.0 mg/kg), an alpha2-adrenergic antagonist, moderately diminished ACTH response, and propranolol (0.1-10 mg/kg), a beta-adrenergic antagonist, did not significantly alter the nicotine-induced hormones secretion. Pretreatment with piroxicam (0.2-2.0 mg/kg), a COX-1 inhibitor, considerably impaired the nicotine-induced ACTH and corticosterone secretion. Compound NS-398 (0.2-5.0 mg/kg), a selective COX-2 blocker did not markedly alter these hormones secretion, and indomethacin (2 mg/kg), a non-selective COX inhibitor significantly diminished ACTH response. These results indicate that systemic nicotine stimulates the HPA axis indirectly, and both adrenergic system and prostaglandins are significantly involved in this stimulation. Noradrenaline, stimulating postsynaptic alpha1-adrenergic receptors, and prostaglandins, synthesized by COX-1 isoenzyme, are of crucial significance in the nicotine-induced ACTH and corticosterone secretion.
尼古丁是下丘脑 - 垂体 - 肾上腺(HPA)轴的一种强效刺激物。全身性尼古丁通过中枢机制,经多种途径刺激垂体前叶促肾上腺皮质激素细胞释放促肾上腺皮质激素(ACTH)以及肾上腺皮质释放皮质酮。尼古丁可能间接刺激下丘脑室旁核,该部位是促肾上腺皮质激素释放激素(CRH)神经元的所在之处,而CRH神经元可激活ACTH的释放。在本研究中,对大鼠体内肾上腺素能系统以及由组成型环氧化酶(COX - 1)和诱导型环氧化酶(COX - 2)合成的前列腺素在尼古丁诱导的HPA反应中的作用进行了研究。尼古丁(腹腔注射2.5 - 5毫克/千克)给药1小时后,显著提高了血浆ACTH和皮质酮水平。在注射尼古丁前15分钟腹腔注射肾上腺素能受体拮抗剂或COX抑制剂,最后一次注射1小时后将大鼠断头。α1 - 肾上腺素能拮抗剂哌唑嗪(0.01 - 0.1毫克/千克)显著降低了尼古丁诱发的ACTH和皮质酮分泌。α2 - 肾上腺素能拮抗剂育亨宾(0.1 - 1.0毫克/千克)适度减弱了ACTH反应,而β - 肾上腺素能拮抗剂普萘洛尔(0.1 - 10毫克/千克)并未显著改变尼古丁诱导的激素分泌。COX - 1抑制剂吡罗昔康(0.2 - 2.0毫克/千克)预处理显著损害了尼古丁诱导的ACTH和皮质酮分泌。选择性COX - 2阻滞剂化合物NS - 398(0.2 - 5.0毫克/千克)并未明显改变这些激素的分泌,而非选择性COX抑制剂吲哚美辛(2毫克/千克)显著减弱了ACTH反应。这些结果表明,全身性尼古丁间接刺激HPA轴,并且肾上腺素能系统和前列腺素均显著参与了这种刺激作用。刺激突触后α1 - 肾上腺素能受体的去甲肾上腺素以及由COX - 1同工酶合成的前列腺素在尼古丁诱导的ACTH和皮质酮分泌中具有至关重要的意义。